Indirect Comparison Topotecan Cervical Carcinoma

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DRUG

cisplatin

50 mg/m2 IV cisplatin on day 1 and then every 3 weeks for 6 courses

DRUG

topotecan

topotecan 0.75 mg/m2 on days 1, 2, and 3. The regimen was repeated every 3 weeks for 6 courses

DRUG

paclitaxel

135 mg/m2 paclitaxel on day 1 and then every 3 weeks for 6 courses

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01345279 - Indirect Comparison Topotecan Cervical Carcinoma | Biotech Hunter | Biotech Hunter